Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation
- PMID: 17890265
- DOI: 10.1093/ndt/gfm651
Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation
Abstract
Since the beginning of organ transplantation, graft preservation has been one of the most important concerns. Ischemia reperfusion injury (IRI), which plays an important role in the quality and function of the graft, is a major cause for increased length of hospitalization and decreased long term graft survival. Among numerous attempts which have been made to minimize graft damage associated with IRI, the use of Thymoglobulin (TG) seems to offer potential benefits. TG is a polyclonal antibody which blocks multiple antigens related to IRI, in addition to its better known T cell depleting effects. This review will focus on the use of TG in preventing IRI in kidney transplantation (KTx) and liver transplantation (LTx). Different studies in experimental and clinical transplantation have shown that TG protects renal and liver grafts from IRI. Improvement in early graft function and decreased delayed graft function (DGF) rates are some of the clinical benefits of TG. Additionally, it is used in patients with hepatorenal syndrome to support the recovery of kidney function after LTx, by allowing reduced exposure to nephrotoxic calcineurin inhibitors as well as improving liver graft function by minimizing IRI. TG can reduce acute rejection rates in kidney and liver transplant recipients, decrease the length of hospital stay, and hence reduce transplantation costs. TG can play an important role in expanding the donor pool in both KTx and LTx by improving long-term graft and patient survival rates which increases the possibility of using marginal donors. Although controversial, the development of post-transplant lymphoproliferative disorder is a potential side effect of TG. No single optimal immunosuppressive regimen has given consistent results in decreasing the graft damage following IRI; however, TG usage in KTx and LTx appears to have some benefits in reducing IRI.
Similar articles
-
Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.Clin Transplant. 2005 Aug;19(4):507-11. doi: 10.1111/j.1399-0012.2005.00375.x. Clin Transplant. 2005. PMID: 16008596 Clinical Trial.
-
A single center experience of combined liver kidney transplantation.Clin Transplant. 2009 Dec;23 Suppl 21:102-14. doi: 10.1111/j.1399-0012.2009.01146.x. Clin Transplant. 2009. PMID: 19930323 Review.
-
Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy.Transplant Proc. 2005 Jan-Feb;37(1):404-6. doi: 10.1016/j.transproceed.2004.12.064. Transplant Proc. 2005. PMID: 15808659 Clinical Trial.
-
Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation?J Transl Med. 2016 Jan 20;14:20. doi: 10.1186/s12967-016-0767-2. J Transl Med. 2016. PMID: 26791565 Free PMC article. Review.
-
Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.BJU Int. 2012 Dec;110(11 Pt C):E1187-95. doi: 10.1111/j.1464-410X.2012.11526.x. Epub 2012 Nov 16. BJU Int. 2012. PMID: 23157304
Cited by
-
Does Rabbit Antithymocyte Globulin (Thymoglobuline®) Have a Role in Avoiding Delayed Graft Function in the Modern Era of Kidney Transplantation?J Transplant. 2018 Jul 12;2018:4524837. doi: 10.1155/2018/4524837. eCollection 2018. J Transplant. 2018. PMID: 30112193 Free PMC article. Review.
-
Glycinergic Signaling in Macrophages and Its Application in Macrophage-Associated Diseases.Front Immunol. 2021 Oct 5;12:762564. doi: 10.3389/fimmu.2021.762564. eCollection 2021. Front Immunol. 2021. PMID: 34675940 Free PMC article. Review.
-
Lymphocyte depletion in experimental hemorrhagic shock in Swine.J Inflamm (Lond). 2012 Sep 25;9(1):34. doi: 10.1186/1476-9255-9-34. J Inflamm (Lond). 2012. PMID: 23009382 Free PMC article.
-
Prophylactic Treatment with Hydrogen Sulphide Can Prevent Renal Ischemia-Reperfusion Injury in L-NAME Induced Hypertensive Rats with Cisplatin-Induced Acute Renal Failure.Life (Basel). 2022 Nov 8;12(11):1819. doi: 10.3390/life12111819. Life (Basel). 2022. PMID: 36362975 Free PMC article.
-
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.Transplantation. 2015 Jan;99(1):197-209. doi: 10.1097/TP.0000000000000250. Transplantation. 2015. PMID: 25083614 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous